BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17267290)

  • 1. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability.
    Simister RJ; Sander JW; Koepp MJ
    Epilepsy Behav; 2007 Mar; 10(2):336-9. PubMed ID: 17267290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?
    Zaccara G; Messori A; Cincotta M; Burchini G
    Acta Neurol Scand; 2006 Sep; 114(3):157-68. PubMed ID: 16911343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative retention rates and long-term tolerability of new antiepileptic drugs.
    Chung S; Wang N; Hank N
    Seizure; 2007 Jun; 16(4):296-304. PubMed ID: 17267243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sensitivity of skin rashes with antiepileptic drug use.
    Hirsch LJ; Arif H; Nahm EA; Buchsbaum R; Resor SR; Bazil CW
    Neurology; 2008 Nov; 71(19):1527-34. PubMed ID: 18981374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD; Wong IC; Polizzi G; Sander JW
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study.
    Sunwoo JS; Park BS; Ahn SJ; Hwang S; Park CY; Jun JS; Kim DW; Lee ST; Jung KH; Park KI; Chu K; Jung KY; Lee SK
    Clin Neuropharmacol; 2017; 40(2):56-62. PubMed ID: 28118167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
    Kim DW; Lee SY; Shon YM; Kim JH
    Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
    Weston J; Bromley R; Jackson CF; Adab N; Clayton-Smith J; Greenhalgh J; Hounsome J; McKay AJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010224. PubMed ID: 27819746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs.
    Gazzola DM; Balcer LJ; French JA
    Epilepsia; 2007 Jul; 48(7):1303-7. PubMed ID: 17521343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.
    Chen B; Choi H; Hirsch LJ; Katz A; Legge A; Buchsbaum R; Detyniecki K
    Epilepsy Behav; 2017 Nov; 76():24-31. PubMed ID: 28931473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
    Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
    Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
    Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
    Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice.
    Bootsma HP; Aldenkamp AP; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsia; 2006; 47 Suppl 2():24-7. PubMed ID: 17105455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of side effects on long-term retention in three new antiepileptic drugs.
    Bootsma HP; Ricker L; Hekster YA; Hulsman J; Lambrechts D; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2009 Jun; 18(5):327-31. PubMed ID: 19110447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
    Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ
    Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
    Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.